The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 743K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

21 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Identification of new quinic acid derivatives as histone deacetylase inhibitors by fluorescence-based cellular assay.EBI
Sungkyunkwan University
Computer-aided identification of new histone deacetylase 6 selective inhibitor with anti-sepsis activity.EBI
Sungkyunkwan University
Discovery and SAR of N-(1-((substituted piperidin-4-yl)methyl)-3-methoxypiperidin-4-yl)-2-methoxybenzamide derivatives: 5-Hydroxytryptamine receptor 4 agonist as a potent prokinetic agent.EBI
Sungkyunkwan University
Flavokawains B and C, melanogenesis inhibitors, isolated from the root of Piper methysticum and synthesis of analogs.EBI
Sungkyunkwan University
Discovery of novel 2-[2-(3-hydroxy-pyridin-2-yl)-thiazol-4-yl]-acetamide derivatives as HIF prolyl 4-hydroxylase inhibitors; SAR, synthesis and modeling evaluation.EBI
Sungkyunkwan University
Discovery of substituted 6-pheny-3H-pyridazin-3-one derivatives as novel c-Met kinase inhibitors.EBI
Sungkyunkwan University
[(4-Hydroxyl-benzo[4,5]thieno[3,2-c]pyridine-3-carbonyl)-amino]-acetic acid derivatives; HIF prolyl 4-hydroxylase inhibitors as oral erythropoietin secretagogues.EBI
Sungkyunkwan University
3D-QSAR studies on sildenafil analogues, selective phosphodiesterase 5 inhibitors.EBI
Sungkyunkwan University
Preparation and structural, biochemical, and pharmaceutical characterizations of bile acid-modified long-acting exendin-4 derivatives.EBI
Sungkyunkwan University
Design and synthesis of 4th generation EGFR inhibitors against human triple (Del19/T790M/C797S) mutation.EBI
Sungkyunkwan University
Development of a tetrahydroindazolone-based HDAC6 inhibitor with in-vivo anti-arthritic activity.EBI
Sungkyunkwan University
Discovery of 2,6-Naphthyridine Analogues as Selective FGFR4 Inhibitors for Hepatocellular Carcinoma.EBI
Sungkyunkwan University
Synthesis and biological evaluation of N-(3-fluorobenzyl)-4-(1-(methyl-dEBI
Sungkyunkwan University
Synthesis and biological evaluation of novel N-benzyltriazolyl-hydroxamate derivatives as selective histone deacetylase 6 inhibitors.EBI
Sungkyunkwan University
Synthesis and biological evaluation of novel purinyl quinazolinone derivatives as PI3Kδ-specific inhibitors for the treatment of hematologic malignancies.EBI
Sungkyunkwan University
Structure-Activity Relationship Study and Biological Evaluation of 2-(Disubstituted phenyl)-indole-5-propanoic Acid Derivatives as GPR40 Full Agonists.EBI
Sungkyunkwan University
Discovery of a Novel Highly Selective Histamine H4 Receptor Antagonist for the Treatment of Atopic Dermatitis.EBI
Sungkyunkwan University
Identification of BR102910 as a selective fibroblast activation protein (FAP) inhibitor.EBI
Sungkyunkwan University
Synthesis and biological evaluation of quinoxaline derivatives as specific c-Met kinase inhibitors.EBI
Sungkyunkwan University
Structure-activity relationship study of thiazolyl-hydroxamate derivatives as selective histone deacetylase 6 inhibitors.EBI
Sungkyunkwan University
SAR Studies of Indole-5-propanoic Acid Derivatives To Develop Novel GPR40 Agonists.EBI
Sungkyunkwan University